AI Tool Comparison
Comparing as AI Medical Research & Clinical Decision SupportDoximity vs Nabla
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.

Doximity
VS

Nabla
Verdict by Category
Detailed category analysis is not available for this comparison.
Detailed Comparison
Feature
Doximity
Nabla
Pricing
FreemiumDoximity is free for all verified US healthcare professionals. Physicians, nurse practitioners, physician assistants, and medical students can access the full platform including Doximity Ask, Scribe, Dialer, secure messaging, and clinical news feed at no cost after NPI credential verification.
Doximity monetizes through B2B enterprise clients: pharmaceutical manufacturers, health systems, and medical recruiting firms pay to access and engage with Doximity's verified physician network through sponsored content, targeted outreach, and workflow integrations.
Enterprise pricing for health system and pharma clients is not publicly disclosed. Contact Doximity through doximity.com for enterprise partnership and B2B pricing inquiries.
FreemiumNabla does not publish exact pricing on its official website; the primary calls-to-action are a free trial (via app.nabla.com) and "Talk to our team" for enterprise sales. Third-party sources consistently report a free tier with usage limits, with paid individual/clinician plans starting around $119/month per provider and higher tiers reported near $239/month per provider. Larger health-system deployments — Nabla's core market, spanning 130+ organizations — are sold via custom enterprise contracts with volume-based pricing, with independent estimates placing typical enterprise rates in the $150-$400/month per provider range depending on scale, EHR integration depth, and features. Exact costs require a sales conversation with Nabla.
Categories
AI Healthcare ToolsAI Research & Education ToolsAI Chatbots
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
Summary
America's largest physician network with free Clinical AI — Ask, Scribe, Dialer for 3M+ clinicians
Ambient AI that turns patient visits into clinical notes, dictation, and coding — right inside the EHR
Doximity Pros & Cons
Pros
- 85%+ of US physicians already on the platform — unmatched distribution advantage for AI clinical tools
- PeerCheck — 10,000-11,000 physician reviewers continuously validate AI answers, unique trust mechanism
- All AI tools completely free for verified US clinicians — zero budget barrier for adoption
- $644.9M FY2026 revenue, NASDAQ: DOCS — financially stable with strong margins (33% net income)
- Pathway Medical acquisition ($63M, Aug 2025) added physician-built clinical evidence dataset to Ask
- 300,000+ unique AI users in Q3 FY2026 — rapid AI adoption within existing physician network
- CEO declared 2026 an AI investment year — aggressive product roadmap with new physician-led AI agents
Cons
- OpenEvidence sued Doximity in June 2025 alleging reverse engineering of proprietary AI technology — legal risk
- AI products currently generate no direct revenue — monetization via B2B pharma/health system clients
- AI tools US-only — not available to international clinicians
- PeerCheck physician review relies on volunteer physician network — coverage can vary by specialty
- Doximity Scribe competes with established ambient documentation tools like DAX Copilot and Nabla with less clinical track record
- Enterprise AI pricing not publicly disclosed
Nabla Pros & Cons
Pros
- Fast note generation, roughly five seconds, that closely mirrors real clinical documentation in independent tests
- Deep native integration with Epic and other major EHRs rather than copy-paste workflows
- Broad specialty and language coverage suited to large, diverse health systems
- Strong compliance posture (HIPAA, SOC 2 Type 2, ISO 27001, GDPR) with configurable data retention
- Backed by peer-reviewed evidence, including a NEJM AI randomized trial showing documentation-time reductions
- Combines documentation, dictation, and coding in one platform instead of separate point tools
Cons
- Pricing isn't published; individuals and smaller practices must go through a sales conversation or rely on third-party estimates to budget
- Primarily built for hospitals and health systems, so solo clinicians and small practices may find it less tailored than SMB-focused scribes
- Relies on ambient recording, so encounters where a patient or clinician can't or won't be recorded aren't well supported
- Some independent reviews note limited customization and quality drop-off on complex, multi-problem visits
- Mobile app store ratings are mixed and based on a relatively small number of reviews compared to the platform's overall clinician base